| 1 | cross-sectional | 6,096 |
| 2 | case-control | 2,451 |
| 3 | quasi-experimental | 491 |
| 4 | sectional | 426 |
| 5 | mixed-methods | 115 |
| 6 | case-crossover | 111 |
| 7 | case-controlled | 107 |
| 8 | multi-ethnic | 103 |
| 9 | questionnaire-based | 92 |
| 10 | matched-pair | 85 |
| 11 | transversal | 83 |
| 12 | case-cohort | 63 |
| 13 | mixed-method | 44 |
| 14 | dismantling | 36 |
| 15 | meta-epidemiological | 24 |
| 16 | case/control | 19 |
| 17 | survey-based | 18 |
| 18 | inter99 | 15 |
| 19 | matched-cohort | 12 |
| 20 | steno-2 | 12 |
| 21 | treatment-outcome | 12 |
| 22 | nej002 | 10 |
| 23 | two-wave | 10 |
| 24 | multiple-ascending-dose | 9 |
| 25 | 45-week | 8 |
| 26 | meta-epidemiologic | 8 |
| 27 | case-referent | 7 |
| 28 | dose-scheduling | 6 |
| 29 | case-case | 5 |
| 30 | use-results | 5 |
| 31 | ages-reykjavik | 4 |
| 32 | bruneck | 4 |
| 33 | crosssectional | 4 |
| 34 | fqd | 4 |
| 35 | 6-site | 3 |
| 36 | across-sectional | 3 |
| 37 | case-match | 3 |
| 38 | chart-review | 3 |
| 39 | confirmational | 3 |
| 40 | genotype-stratified | 3 |
| 41 | hyper-endemic | 3 |
| 42 | metaepidemiological | 3 |
| 43 | prospective-longitudinal | 3 |
| 44 | random-sample | 3 |
| 45 | stated-preference | 3 |
| 46 | wholeheart | 3 |
| 47 | 1992/93 | 2 |
| 48 | 27-question | 2 |
| 49 | 32-question | 2 |
| 50 | bioair | 2 |
| 51 | carrier-control | 2 |
| 52 | case–control | 2 |
| 53 | control/cohort | 2 |
| 54 | descriptive-analytic | 2 |
| 55 | descriptive-explorative | 2 |
| 56 | direct-to-vial | 2 |
| 57 | doppler-hemodynamic | 2 |
| 58 | exercise-recovery | 2 |
| 59 | fastact-2 | 2 |
| 60 | full-population | 2 |
| 61 | germany-wide | 2 |
| 62 | half-crossover | 2 |
| 63 | medico-ethnobotanical | 2 |
| 64 | midabdominal | 2 |
| 65 | multiple-attack | 2 |
| 66 | mums4mums | 2 |
| 67 | norming | 2 |
| 68 | phonomechanographic | 2 |
| 69 | prevenir | 2 |
| 70 | probability-cluster | 2 |
| 71 | responder-enriched | 2 |
| 72 | separate-group | 2 |
| 73 | susceptibility-reykjavik | 2 |
| 74 | torque-angle | 2 |
| 75 | 110-d | 1 |
| 76 | 12-week/26-week | 1 |
| 77 | 125-d | 1 |
| 78 | 16-myocardial | 1 |
| 79 | 16-question | 1 |
| 80 | 24month | 1 |
| 81 | 25-center | 1 |
| 82 | 255-item | 1 |
| 83 | 29-question | 1 |
| 84 | 3000-person | 1 |
| 85 | 32-patient | 1 |
| 86 | 33-question | 1 |
| 87 | 39-day | 1 |
| 88 | 399-patient | 1 |
| 89 | 47-question | 1 |
| 90 | 5-county | 1 |
| 91 | 56-wk | 1 |
| 92 | 6-county | 1 |
| 93 | 6-question | 1 |
| 94 | 60-question | 1 |
| 95 | 61-question | 1 |
| 96 | 63-question | 1 |
| 97 | 67-d | 1 |
| 98 | 7.5-mm-diam | 1 |
| 99 | 72-patient | 1 |
| 100 | 78-d | 1 |
| 101 | 96-question | 1 |
| 102 | basin-wide | 1 |
| 103 | bias.individual | 1 |
| 104 | bion | 1 |
| 105 | blinded-endopoint | 1 |
| 106 | botfly-endemic | 1 |
| 107 | campinarana | 1 |
| 108 | canadian/european | 1 |
| 109 | case-match-control | 1 |
| 110 | chart-abstraction | 1 |
| 111 | checklist-type | 1 |
| 112 | cholera-endemic | 1 |
| 113 | city-center | 1 |
| 114 | clinico-mycological | 1 |
| 115 | cluster-sample | 1 |
| 116 | cluster-stratified | 1 |
| 117 | cocaine-treatment | 1 |
| 118 | conace | 1 |
| 119 | conformer-resolved | 1 |
| 120 | cross-analytical | 1 |
| 121 | cross-sectional/cohort | 1 |
| 122 | cross-sessional | 1 |
| 123 | crossover-experimental | 1 |
| 124 | cyto-hystologic | 1 |
| 125 | delphi-style | 1 |
| 126 | descriptive-correlative | 1 |
| 127 | diagnosis-prescribing | 1 |
| 128 | diagnosis-prescription | 1 |
| 129 | diagnostic-test | 1 |
| 130 | doppler-echocardiographuc | 1 |
| 131 | double-blind-cross-over | 1 |
| 132 | european-funded | 1 |
| 133 | extensively-documented | 1 |
| 134 | five-nation | 1 |
| 135 | gastrointestinal/qol | 1 |
| 136 | health/lifestyle | 1 |
| 137 | health2010 | 1 |
| 138 | hemodynamic-radionuclide | 1 |
| 139 | human-readable | 1 |
| 140 | human-volunteer | 1 |
| 141 | i-us-os-ang | 1 |
| 142 | large-population | 1 |
| 143 | ligatures.this | 1 |
| 144 | macroradiographic | 1 |
| 145 | malaria-holoendemic | 1 |
| 146 | mandatory-random | 1 |
| 147 | measurement-focused | 1 |
| 148 | medical-ethnographic | 1 |
| 149 | medico-economial | 1 |
| 150 | merged-beam | 1 |
| 151 | metabolic-functional | 1 |
| 152 | method-comparison | 1 |
| 153 | method-of-difference | 1 |
| 154 | minutes.primary | 1 |
| 155 | mix-methodology | 1 |
| 156 | mixed-methodology | 1 |
| 157 | monika/kora | 1 |
| 158 | much-neglected | 1 |
| 159 | multi-baseline | 1 |
| 160 | multi-interdisciplinary | 1 |
| 161 | multi-platform | 1 |
| 162 | multilaboratory | 1 |
| 163 | nct00209795ifakara | 1 |
| 164 | nct01867502 | 1 |
| 165 | nematological | 1 |
| 166 | neuro-histological | 1 |
| 167 | observational/questionnaire | 1 |
| 168 | p2rx7 | 1 |
| 169 | paper/online | 1 |
| 170 | pharmacoscintigraphic | 1 |
| 171 | phase-i-toxicity | 1 |
| 172 | phase1 | 1 |
| 173 | phenomenologic-hermeneutic | 1 |
| 174 | population-base | 1 |
| 175 | post-encounter | 1 |
| 176 | post-experience | 1 |
| 177 | post-osce | 1 |
| 178 | potentially-confounded | 1 |
| 179 | proof-of-principal | 1 |
| 180 | qualitative-phenomenological | 1 |
| 181 | quasi-experimental/interpretive | 1 |
| 182 | regression-type | 1 |
| 183 | reliability-tested | 1 |
| 184 | repeat-interview | 1 |
| 185 | researcher-directed | 1 |
| 186 | result-oriented | 1 |
| 187 | selenium-low | 1 |
| 188 | six-cell | 1 |
| 189 | socio-acoustic | 1 |
| 190 | socio-hygienic | 1 |
| 191 | street-intercept | 1 |
| 192 | structure-performance | 1 |
| 193 | sulpyrine-challenge | 1 |
| 194 | symptoms-only | 1 |
| 195 | time-corrected | 1 |
| 196 | training/validation | 1 |
| 197 | trans-sectional | 1 |
| 198 | transcription-qpcr | 1 |
| 199 | tristate | 1 |
| 200 | twenty-five-question | 1 |
| 201 | uplc/tof-ms-based | 1 |
| 202 | vaccination-challenge | 1 |
| 203 | waitlist-group | 1 |
| 204 | word-association | 1 |
| 1 | 110-d | 1 |
| 2 | 12-week/26-week | 1 |
| 3 | 125-d | 1 |
| 4 | 16-myocardial | 1 |
| 5 | 16-question | 1 |
| 6 | 1992/93 | 2 |
| 7 | 24month | 1 |
| 8 | 25-center | 1 |
| 9 | 255-item | 1 |
| 10 | 27-question | 2 |
| 11 | 29-question | 1 |
| 12 | 3000-person | 1 |
| 13 | 32-patient | 1 |
| 14 | 32-question | 2 |
| 15 | 33-question | 1 |
| 16 | 39-day | 1 |
| 17 | 399-patient | 1 |
| 18 | 45-week | 8 |
| 19 | 47-question | 1 |
| 20 | 5-county | 1 |
| 21 | 56-wk | 1 |
| 22 | 6-county | 1 |
| 23 | 6-question | 1 |
| 24 | 6-site | 3 |
| 25 | 60-question | 1 |
| 26 | 61-question | 1 |
| 27 | 63-question | 1 |
| 28 | 67-d | 1 |
| 29 | 7.5-mm-diam | 1 |
| 30 | 72-patient | 1 |
| 31 | 78-d | 1 |
| 32 | 96-question | 1 |
| 33 | across-sectional | 3 |
| 34 | ages-reykjavik | 4 |
| 35 | basin-wide | 1 |
| 36 | bias.individual | 1 |
| 37 | bioair | 2 |
| 38 | bion | 1 |
| 39 | blinded-endopoint | 1 |
| 40 | botfly-endemic | 1 |
| 41 | bruneck | 4 |
| 42 | campinarana | 1 |
| 43 | canadian/european | 1 |
| 44 | carrier-control | 2 |
| 45 | case-case | 5 |
| 46 | case-cohort | 63 |
| 47 | case-control | 2,451 |
| 48 | case-controlled | 107 |
| 49 | case-crossover | 111 |
| 50 | case-match | 3 |
| 51 | case-match-control | 1 |
| 52 | case-referent | 7 |
| 53 | case/control | 19 |
| 54 | case–control | 2 |
| 55 | chart-abstraction | 1 |
| 56 | chart-review | 3 |
| 57 | checklist-type | 1 |
| 58 | cholera-endemic | 1 |
| 59 | city-center | 1 |
| 60 | clinico-mycological | 1 |
| 61 | cluster-sample | 1 |
| 62 | cluster-stratified | 1 |
| 63 | cocaine-treatment | 1 |
| 64 | conace | 1 |
| 65 | confirmational | 3 |
| 66 | conformer-resolved | 1 |
| 67 | control/cohort | 2 |
| 68 | cross-analytical | 1 |
| 69 | cross-sectional | 6,096 |
| 70 | cross-sectional/cohort | 1 |
| 71 | cross-sessional | 1 |
| 72 | crossover-experimental | 1 |
| 73 | crosssectional | 4 |
| 74 | cyto-hystologic | 1 |
| 75 | delphi-style | 1 |
| 76 | descriptive-analytic | 2 |
| 77 | descriptive-correlative | 1 |
| 78 | descriptive-explorative | 2 |
| 79 | diagnosis-prescribing | 1 |
| 80 | diagnosis-prescription | 1 |
| 81 | diagnostic-test | 1 |
| 82 | direct-to-vial | 2 |
| 83 | dismantling | 36 |
| 84 | doppler-echocardiographuc | 1 |
| 85 | doppler-hemodynamic | 2 |
| 86 | dose-scheduling | 6 |
| 87 | double-blind-cross-over | 1 |
| 88 | european-funded | 1 |
| 89 | exercise-recovery | 2 |
| 90 | extensively-documented | 1 |
| 91 | fastact-2 | 2 |
| 92 | five-nation | 1 |
| 93 | fqd | 4 |
| 94 | full-population | 2 |
| 95 | gastrointestinal/qol | 1 |
| 96 | genotype-stratified | 3 |
| 97 | germany-wide | 2 |
| 98 | half-crossover | 2 |
| 99 | health/lifestyle | 1 |
| 100 | health2010 | 1 |
| 101 | hemodynamic-radionuclide | 1 |
| 102 | human-readable | 1 |
| 103 | human-volunteer | 1 |
| 104 | hyper-endemic | 3 |
| 105 | i-us-os-ang | 1 |
| 106 | inter99 | 15 |
| 107 | large-population | 1 |
| 108 | ligatures.this | 1 |
| 109 | macroradiographic | 1 |
| 110 | malaria-holoendemic | 1 |
| 111 | mandatory-random | 1 |
| 112 | matched-cohort | 12 |
| 113 | matched-pair | 85 |
| 114 | measurement-focused | 1 |
| 115 | medical-ethnographic | 1 |
| 116 | medico-economial | 1 |
| 117 | medico-ethnobotanical | 2 |
| 118 | merged-beam | 1 |
| 119 | meta-epidemiologic | 8 |
| 120 | meta-epidemiological | 24 |
| 121 | metabolic-functional | 1 |
| 122 | metaepidemiological | 3 |
| 123 | method-comparison | 1 |
| 124 | method-of-difference | 1 |
| 125 | midabdominal | 2 |
| 126 | minutes.primary | 1 |
| 127 | mix-methodology | 1 |
| 128 | mixed-method | 44 |
| 129 | mixed-methodology | 1 |
| 130 | mixed-methods | 115 |
| 131 | monika/kora | 1 |
| 132 | much-neglected | 1 |
| 133 | multi-baseline | 1 |
| 134 | multi-ethnic | 103 |
| 135 | multi-interdisciplinary | 1 |
| 136 | multi-platform | 1 |
| 137 | multilaboratory | 1 |
| 138 | multiple-ascending-dose | 9 |
| 139 | multiple-attack | 2 |
| 140 | mums4mums | 2 |
| 141 | nct00209795ifakara | 1 |
| 142 | nct01867502 | 1 |
| 143 | nej002 | 10 |
| 144 | nematological | 1 |
| 145 | neuro-histological | 1 |
| 146 | norming | 2 |
| 147 | observational/questionnaire | 1 |
| 148 | p2rx7 | 1 |
| 149 | paper/online | 1 |
| 150 | pharmacoscintigraphic | 1 |
| 151 | phase-i-toxicity | 1 |
| 152 | phase1 | 1 |
| 153 | phenomenologic-hermeneutic | 1 |
| 154 | phonomechanographic | 2 |
| 155 | population-base | 1 |
| 156 | post-encounter | 1 |
| 157 | post-experience | 1 |
| 158 | post-osce | 1 |
| 159 | potentially-confounded | 1 |
| 160 | prevenir | 2 |
| 161 | probability-cluster | 2 |
| 162 | proof-of-principal | 1 |
| 163 | prospective-longitudinal | 3 |
| 164 | qualitative-phenomenological | 1 |
| 165 | quasi-experimental | 491 |
| 166 | quasi-experimental/interpretive | 1 |
| 167 | questionnaire-based | 92 |
| 168 | random-sample | 3 |
| 169 | regression-type | 1 |
| 170 | reliability-tested | 1 |
| 171 | repeat-interview | 1 |
| 172 | researcher-directed | 1 |
| 173 | responder-enriched | 2 |
| 174 | result-oriented | 1 |
| 175 | sectional | 426 |
| 176 | selenium-low | 1 |
| 177 | separate-group | 2 |
| 178 | six-cell | 1 |
| 179 | socio-acoustic | 1 |
| 180 | socio-hygienic | 1 |
| 181 | stated-preference | 3 |
| 182 | steno-2 | 12 |
| 183 | street-intercept | 1 |
| 184 | structure-performance | 1 |
| 185 | sulpyrine-challenge | 1 |
| 186 | survey-based | 18 |
| 187 | susceptibility-reykjavik | 2 |
| 188 | symptoms-only | 1 |
| 189 | time-corrected | 1 |
| 190 | torque-angle | 2 |
| 191 | training/validation | 1 |
| 192 | trans-sectional | 1 |
| 193 | transcription-qpcr | 1 |
| 194 | transversal | 83 |
| 195 | treatment-outcome | 12 |
| 196 | tristate | 1 |
| 197 | twenty-five-question | 1 |
| 198 | two-wave | 10 |
| 199 | uplc/tof-ms-based | 1 |
| 200 | use-results | 5 |
| 201 | vaccination-challenge | 1 |
| 202 | waitlist-group | 1 |
| 203 | wholeheart | 3 |
| 204 | word-association | 1 |
| 1 | health2010 | 1 |
| 2 | phase1 | 1 |
| 3 | steno-2 | 12 |
| 4 | fastact-2 | 2 |
| 5 | nej002 | 10 |
| 6 | nct01867502 | 1 |
| 7 | 1992/93 | 2 |
| 8 | p2rx7 | 1 |
| 9 | inter99 | 15 |
| 10 | campinarana | 1 |
| 11 | nct00209795ifakara | 1 |
| 12 | monika/kora | 1 |
| 13 | meta-epidemiologic | 8 |
| 14 | cyto-hystologic | 1 |
| 15 | pharmacoscintigraphic | 1 |
| 16 | macroradiographic | 1 |
| 17 | phonomechanographic | 2 |
| 18 | medical-ethnographic | 1 |
| 19 | doppler-hemodynamic | 2 |
| 20 | cholera-endemic | 1 |
| 21 | hyper-endemic | 3 |
| 22 | botfly-endemic | 1 |
| 23 | malaria-holoendemic | 1 |
| 24 | socio-hygienic | 1 |
| 25 | multi-ethnic | 103 |
| 26 | socio-acoustic | 1 |
| 27 | phenomenologic-hermeneutic | 1 |
| 28 | descriptive-analytic | 2 |
| 29 | doppler-echocardiographuc | 1 |
| 30 | 110-d | 1 |
| 31 | 125-d | 1 |
| 32 | 67-d | 1 |
| 33 | 78-d | 1 |
| 34 | european-funded | 1 |
| 35 | potentially-confounded | 1 |
| 36 | responder-enriched | 2 |
| 37 | genotype-stratified | 3 |
| 38 | cluster-stratified | 1 |
| 39 | case-controlled | 107 |
| 40 | questionnaire-based | 92 |
| 41 | uplc/tof-ms-based | 1 |
| 42 | survey-based | 18 |
| 43 | measurement-focused | 1 |
| 44 | much-neglected | 1 |
| 45 | researcher-directed | 1 |
| 46 | time-corrected | 1 |
| 47 | result-oriented | 1 |
| 48 | extensively-documented | 1 |
| 49 | reliability-tested | 1 |
| 50 | conformer-resolved | 1 |
| 51 | mixed-method | 44 |
| 52 | fqd | 4 |
| 53 | conace | 1 |
| 54 | structure-performance | 1 |
| 55 | post-experience | 1 |
| 56 | stated-preference | 3 |
| 57 | method-of-difference | 1 |
| 58 | post-osce | 1 |
| 59 | hemodynamic-radionuclide | 1 |
| 60 | basin-wide | 1 |
| 61 | germany-wide | 2 |
| 62 | sulpyrine-challenge | 1 |
| 63 | vaccination-challenge | 1 |
| 64 | human-readable | 1 |
| 65 | torque-angle | 2 |
| 66 | random-sample | 3 |
| 67 | cluster-sample | 1 |
| 68 | delphi-style | 1 |
| 69 | health/lifestyle | 1 |
| 70 | treatment-outcome | 12 |
| 71 | multi-baseline | 1 |
| 72 | paper/online | 1 |
| 73 | regression-type | 1 |
| 74 | checklist-type | 1 |
| 75 | observational/questionnaire | 1 |
| 76 | population-base | 1 |
| 77 | case-case | 5 |
| 78 | multiple-ascending-dose | 9 |
| 79 | tristate | 1 |
| 80 | 6-site | 3 |
| 81 | two-wave | 10 |
| 82 | descriptive-correlative | 1 |
| 83 | descriptive-explorative | 2 |
| 84 | quasi-experimental/interpretive | 1 |
| 85 | i-us-os-ang | 1 |
| 86 | diagnosis-prescribing | 1 |
| 87 | dismantling | 36 |
| 88 | dose-scheduling | 6 |
| 89 | norming | 2 |
| 90 | case-match | 3 |
| 91 | 24month | 1 |
| 92 | multiple-attack | 2 |
| 93 | bruneck | 4 |
| 94 | 45-week | 8 |
| 95 | 12-week/26-week | 1 |
| 96 | ages-reykjavik | 4 |
| 97 | susceptibility-reykjavik | 2 |
| 98 | 56-wk | 1 |
| 99 | clinico-mycological | 1 |
| 100 | meta-epidemiological | 24 |
| 101 | metaepidemiological | 3 |
| 102 | qualitative-phenomenological | 1 |
| 103 | nematological | 1 |
| 104 | neuro-histological | 1 |
| 105 | medico-ethnobotanical | 2 |
| 106 | cross-analytical | 1 |
| 107 | 16-myocardial | 1 |
| 108 | medico-economial | 1 |
| 109 | direct-to-vial | 2 |
| 110 | prospective-longitudinal | 3 |
| 111 | midabdominal | 2 |
| 112 | cross-sessional | 1 |
| 113 | confirmational | 3 |
| 114 | sectional | 426 |
| 115 | trans-sectional | 1 |
| 116 | cross-sectional | 6,096 |
| 117 | across-sectional | 3 |
| 118 | crosssectional | 4 |
| 119 | metabolic-functional | 1 |
| 120 | proof-of-principal | 1 |
| 121 | transversal | 83 |
| 122 | quasi-experimental | 491 |
| 123 | crossover-experimental | 1 |
| 124 | bias.individual | 1 |
| 125 | six-cell | 1 |
| 126 | gastrointestinal/qol | 1 |
| 127 | case-control | 2,451 |
| 128 | case-match-control | 1 |
| 129 | carrier-control | 2 |
| 130 | case/control | 19 |
| 131 | case–control | 2 |
| 132 | merged-beam | 1 |
| 133 | 7.5-mm-diam | 1 |
| 134 | 255-item | 1 |
| 135 | mandatory-random | 1 |
| 136 | multi-platform | 1 |
| 137 | canadian/european | 1 |
| 138 | bion | 1 |
| 139 | training/validation | 1 |
| 140 | word-association | 1 |
| 141 | large-population | 1 |
| 142 | full-population | 2 |
| 143 | five-nation | 1 |
| 144 | chart-abstraction | 1 |
| 145 | diagnosis-prescription | 1 |
| 146 | 60-question | 1 |
| 147 | 61-question | 1 |
| 148 | 32-question | 2 |
| 149 | 33-question | 1 |
| 150 | 63-question | 1 |
| 151 | 6-question | 1 |
| 152 | 16-question | 1 |
| 153 | 96-question | 1 |
| 154 | 27-question | 2 |
| 155 | 47-question | 1 |
| 156 | 29-question | 1 |
| 157 | twenty-five-question | 1 |
| 158 | method-comparison | 1 |
| 159 | 3000-person | 1 |
| 160 | separate-group | 2 |
| 161 | waitlist-group | 1 |
| 162 | transcription-qpcr | 1 |
| 163 | human-volunteer | 1 |
| 164 | 25-center | 1 |
| 165 | city-center | 1 |
| 166 | post-encounter | 1 |
| 167 | probability-cluster | 2 |
| 168 | double-blind-cross-over | 1 |
| 169 | case-crossover | 111 |
| 170 | half-crossover | 2 |
| 171 | bioair | 2 |
| 172 | matched-pair | 85 |
| 173 | prevenir | 2 |
| 174 | mixed-methods | 115 |
| 175 | ligatures.this | 1 |
| 176 | mums4mums | 2 |
| 177 | use-results | 5 |
| 178 | 32-patient | 1 |
| 179 | 72-patient | 1 |
| 180 | 399-patient | 1 |
| 181 | cocaine-treatment | 1 |
| 182 | case-referent | 7 |
| 183 | blinded-endopoint | 1 |
| 184 | street-intercept | 1 |
| 185 | wholeheart | 3 |
| 186 | matched-cohort | 12 |
| 187 | case-cohort | 63 |
| 188 | cross-sectional/cohort | 1 |
| 189 | control/cohort | 2 |
| 190 | diagnostic-test | 1 |
| 191 | chart-review | 3 |
| 192 | repeat-interview | 1 |
| 193 | selenium-low | 1 |
| 194 | 39-day | 1 |
| 195 | mixed-methodology | 1 |
| 196 | mix-methodology | 1 |
| 197 | symptoms-only | 1 |
| 198 | minutes.primary | 1 |
| 199 | multi-interdisciplinary | 1 |
| 200 | exercise-recovery | 2 |
| 201 | multilaboratory | 1 |
| 202 | phase-i-toxicity | 1 |
| 203 | 5-county | 1 |
| 204 | 6-county | 1 |